P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease ; volume:15 ; number:1 ; day:7 ; month:6 ; year:2023 ; pages:1-19 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (7.6.2023), 1-19, 12.2023
- Urheber
-
Bianchi, Carolina
Alvarez-Castelao, Beatriz
Sebastián-Serrano, Álvaro
Lauro, Caterina Di
Soria-Tobar, Lucia
Nicke, Annette
Engel, Tobias
Díaz-Hernández, Miguel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-023-01258-x
- URN
-
urn:nbn:de:101:1-2023091614472159677220
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bianchi, Carolina
- Alvarez-Castelao, Beatriz
- Sebastián-Serrano, Álvaro
- Lauro, Caterina Di
- Soria-Tobar, Lucia
- Nicke, Annette
- Engel, Tobias
- Díaz-Hernández, Miguel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Role of the ubiquitin proteasome system in Alzheimer's disease
Perturbations of proteostasis networks in Alzheimer´s disease: Focus on the ubiquitin proteasome system
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Ubiquitin proteasome system and myopathies
Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology
Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
Role of the ubiquitin proteasome system in Alzheimer's disease
Perturbations of proteostasis networks in Alzheimer´s disease: Focus on the ubiquitin proteasome system
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Ubiquitin proteasome system and myopathies
Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology
Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
Role of the ubiquitin proteasome system in Alzheimer's disease
Perturbations of proteostasis networks in Alzheimer´s disease: Focus on the ubiquitin proteasome system
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Ubiquitin proteasome system and myopathies
Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology
Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease